On May 15, 2026, China’s National Medical Products Administration (“NMPA”) issued the Implementat...
Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...
Reporting on ground from API China 2026, BioSpectrum Asia observed strong international interest aro...
4D Path, a US-based company dedicated to personalising cancer care through a novel, physics-informed approach to predict...
Expecto Health Science, a full-service Asia-Pacific Contract Research Organization (CRO), announced a strategic pa...
Insilico Medicine, a clinical-stage biotechnology company powered by generative artificial intelligence (AI) and automat...
Hong Kong headquartered Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven biotechnology...
SK pharmteco, a leading global contract development and manufacturing organization (CDMO), and Prozomix, a pioneer ...
Hong Kong headquartered Insilico Medicine, a clinical-stage drug discovery and development company driven by genera...
The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development ...
In conversation with Ankit Kankar, General Manager at BioSpectrum Asia, Alexander Seyf, CEO and co found...
In his keynote session, Heath Coats shared practical regulatory insights drawn from his experience both ...
Israel-based Evogene has announced a collaboration with the pioneering research group of Dr Mark Adams, a leading c...
US-based BostonGene, the developer of the leading AI foundation model for tumour and immune biology, has announced ...
Galux, a South Korea-based biotech startup pioneering artificial intelligence (AI)-driven protein therapeutics design, h...
Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understandi...
Pierre Fabre Laboratories and Iktos, a global leader in Artificial Intelligence (AI) and Robotics on drug discovery, ann...
Iktos, a leader in Artificial Intelligence (AI) and Robotics applied to drug discovery, announced a landmark multi-targe...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Japan-based Meiji Seika Pharma has entered into a partnership agreement with MBC BioLabs which is a private organisation...
At an AbbVie-sponsored symposium at the ESMO Asia Congress 2025, experts gathered to address platinum resistance in adva...
US-based BostonGene, developer of the leading AI foundation model for cancer and the immune system, and Kyoto ...
Hong Kong-based Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibod...
Japan's Chugai Pharmaceutical and US-based Rani Therapeutics, LLC, a subsidiary of Rani Therapeutics Holdings, Inc., hav...
